Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Praxis Precision Medicines (PRAX) EBITDA Margin (2023 - 2025)

Historic EBITDA Margin for Praxis Precision Medicines (PRAX) over the last 2 years, with Q4 2024 value amounting to 856.97%.

  • Praxis Precision Medicines' EBITDA Margin rose 45422500.0% to 856.97% in Q4 2024 from the same period last year, while for Sep 2025 it was 3927.51%, marking a year-over-year increase of 62914900.0%. This contributed to the annual value of 2340.29% for FY2024, which is 28241200.0% up from last year.
  • Latest data reveals that Praxis Precision Medicines reported EBITDA Margin of 856.97% as of Q4 2024, which was up 45422500.0% from 18819.54% recorded in Q3 2024.
  • In the past 5 years, Praxis Precision Medicines' EBITDA Margin registered a high of 856.97% during Q4 2024, and its lowest value of 18819.54% during Q3 2024.